Efficacy of DAAs in the Treatment of Chronic HCV: Real-World Data from the Private Health-Care Sector of the Kingdom of Saudi Arabia
Background and Aim: The hepatitis C virus (HCV) is considered a global health challenge that requires urgent interventions for prevention and control. In this study, we aimed to evaluate the effectiveness of direct-acting antiviral agents (DAAs) for HCV-infected patients in the Kingdom of Saudi Arab...
Saved in:
Main Authors: | Almoutaz Hashim (Author), Fadia Almahdi (Author), Emad Aldin Albaba (Author), Ohoud Barkia (Author), Reem Alkasam (Author), Asmaa Almahmoud (Author), Ahmed Nabil (Author), Ayman Alsulaimani (Author), Mahmoud Mosli (Author) |
---|---|
Format: | Book |
Published: |
Springer,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019) -
Anti-HCV DAA are needed whatever liver fibrosis is. The cons
by: Pablo Barreiro
Published: (2016) -
Anti-HCV DAA are needed whatever liver fibrosis is. The pros
by: Albert Tran
Published: (2016) -
Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
by: Fabrizio Fabrizi, et al.
Published: (2021) -
Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
by: Hrvoje Roguljic, et al.
Published: (2021)